BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Alcohol, Quercetin, rs2300478, SNCA, Response to oxidative stress, Obesity, Embryo)
Bookmark Forward

QuickView for Sunitinib (compound)


Genetic Markers

Most Correlated Genes

  1. SERPINA3
  2. LCN2
  3. RBP4
  4. AGR2
  5. NPR3
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. cytosol
  2. vesicle
  3. regulation of nitrogen compound metabolic process
  4. organic cyclic compound binding
  5. heterocyclic compound binding
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Breast cancer MDA-MB-231 xenografts treated with sunitinib
  2. Renal cell carcinoma 786-O or A-498 cell xenografts of mice treated with sorafenib or sunitinib
  3. Kidney samples from metastatic clear cell renal cell carcinoma patients treated with sunitinib
  4. Renal cell carcinoma from patients treated with neoadjuvant sunitinib
  5. Rhabdomyosarcoma A-204 cells treated with dasatinib or pazopanib or sunitinib
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. The Effects of Sunitinib in Healthy and Cisplatin-Induced Rats.
  2. Cytoreductive nephrectomy and exposure to sunitinib - a post hoc analysis of the Immediate Surgery o…
  3. Pre-clinical safety of topically administered sunitinib-loaded lipid and polymeric nanocarriers targ…
  4. Shell-sheddable dendritic polyglycerol sulfates loaded with sunitinib for inhibition of tumor angiog…
  5. Magnetic solid phase extraction of Sunitinib malate in urine samples assisted with mixed hemimicelle…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Thyroid Cancer and Sunitinib
  2. Sunitinib in Refractory Adrenocortical Carcinoma
  3. Bevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell Carcinoma
  4. A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma
  5. Gemzar, Cisp, Sunitinib Urothelial Ca
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.